20213

0

SUNREST

img img img img
No Data Available

SUNREST LIFESCIENCE LTD Share Price Update

As of the latest trading session, SUNREST LIFESCIENCE LTD is trading at ₹36.1, down by ₹-0.20 or -0.55% from its previous close. The stock has moved between ₹36.10 and ₹37.85 today. Over the past year, the stock has delivered a return of -26.03%. In the last month, it has returned -1.89%.

SUNREST LIFESCIENCE LTD performance

Today’s low Today’s high
₹ 36.10 ₹ 37.85
₹ 36.10
52 week low 52 week high
₹ 26.37 ₹ 54.44
₹ 36.10
Open Price ₹ 37.85
Prev. Close ₹ 36.30
Volume (Shares) 3200.00
Total traded value ₹ 1.15
Upper Circuit ₹ 43.55
Lower Circuit ₹ 29.05
info

Investment Returns

Over 1 Month -1.89% Over 3 Months 23.25% Over 6 Months -16.99% Over 1 Year -26.03%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SUNREST LIFESCIENCE LTD fundamentals


  • Market cap (Cr) 31.00
  • P/E Ratio (TTM) 15.58
  • Beta 0.94
  • Book Value / share 36.35
  • Return on equity 13.18%
  • EPS (TTM) 2.33
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 1.23
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

SUNREST LIFESCIENCE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars SEP 2023 (Values in Cr)
Revenue 6.84
Operating Expense 0.00
Net Profit 1.23
Net Profit Margin (%) 17.98
Earnings Per Share (EPS) 4.12
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 5.64
Operating Expense 4.67
Net Profit 0.75
Net Profit Margin (%) 13.29
Earnings Per Share (EPS) 2.50
EBITDA 1.00
Effective Tax Rate (%) 22.68
Particulars MAR 2023 (Values in Cr)
Revenue 6.84
Operating Expense 0.00
Net Profit -0.32
Net Profit Margin (%) -4.67
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 33.12
Operating Expense 30.51
Net Profit 2.00
Net Profit Margin (%) 6.03
Earnings Per Share (EPS) 4.66
EBITDA 2.99
Effective Tax Rate (%) 23.37
Particulars MAR 2024 (Values in Cr)
Revenue 29.48
Operating Expense 28.89
Net Profit 0.23
Net Profit Margin (%) 0.78
Earnings Per Share (EPS) 0.68
EBITDA 0.90
Effective Tax Rate (%) 62.71
Particulars MAR 2023 (Values in Cr)
Revenue 24.64
Operating Expense 21.93
Net Profit 2.04
Net Profit Margin (%) 8.27
Earnings Per Share (EPS) 6.81
EBITDA 2.93
Effective Tax Rate (%) 25.54
Particulars MAR 2022 (Values in Cr)
Revenue 26.89
Operating Expense 25.86
Net Profit 0.78
Net Profit Margin (%) 2.90
Earnings Per Share (EPS) 777.10
EBITDA 1.12
Effective Tax Rate (%) 25.71
Particulars MAR 2021 (Values in Cr)
Revenue 16.95
Operating Expense 16.73
Net Profit 0.17
Net Profit Margin (%) 1.00
Earnings Per Share (EPS) 165.50
EBITDA 0.27
Effective Tax Rate (%) 27.27
Particulars MAR 2025 (Values in Cr)
Book Value / Share 37.72
ROE % 13.18
ROCE % 13.53
Total Debt to Total Equity 0.41
EBITDA Margin 9.06
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.06
ROE % 2.66
ROCE % 6.41
Total Debt to Total Equity 0.48
EBITDA Margin 3.09
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.38
ROE % 97.61
ROCE % 58.58
Total Debt to Total Equity 1.29
EBITDA Margin 11.89
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1070.40
ROE % 114.71
ROCE % 30.92
Total Debt to Total Equity 4.09
EBITDA Margin 4.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 294.90
ROE % 80.95
ROCE % 9.58
Total Debt to Total Equity 10.93
EBITDA Margin 1.65
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.27
Total Assets 35.15
Total Liabilities 35.15
Total Equity 16.18
Share Outstanding 0
Price to Book Ratio 1.42
Return on Assets (%) 5.68
Return on Capital (%) 8.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.28
Total Assets 25.15
Total Liabilities 25.15
Total Equity 14.18
Share Outstanding 0
Price to Book Ratio 1.85
Return on Assets (%) 0.89
Return on Capital (%) 1.11
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 16.71
Total Liabilities 16.71
Total Equity 3.11
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 12.22
Return on Capital (%) 38.87
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.48
Total Assets 13.01
Total Liabilities 13.01
Total Equity 1.07
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 5.96
Return on Capital (%) 18.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.37
Total Assets 9.48
Total Liabilities 9.48
Total Equity 0.29
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.74
Return on Capital (%) 6.34
Particulars MAR 2025 (Values in Cr)
Net Income 2.60
Cash from Operations 1.90
Cash from Investing -1.13
Cash from Financing -0.29
Net change in Cash -0.01
Free Cash Flow 3.27
Particulars MAR 2024 (Values in Cr)
Net Income 0.59
Cash from Operations -13.96
Cash from Investing 0.00
Cash from Financing 14.64
Net change in Cash -0.16
Free Cash Flow -13.95
Particulars MAR 2023 (Values in Cr)
Net Income 2.74
Cash from Operations 1.53
Cash from Investing -0.03
Cash from Financing -1.15
Net change in Cash -0.03
Free Cash Flow 1.54
Particulars MAR 2022 (Values in Cr)
Net Income 1.05
Cash from Operations -0.35
Cash from Investing -0.35
Cash from Financing 0.89
Net change in Cash 0.10
Free Cash Flow 0.11
Particulars MAR 2021 (Values in Cr)
Net Income 0.22
Cash from Operations 0.22
Cash from Investing -0.16
Cash from Financing 0.03
Net change in Cash 0.02
Free Cash Flow 0.38
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.31 13.99 1.67 247.60 23.12 40.44
BLISS GVS PHARMA LTD 267.75 25.60 2.50 2832.50 105.05 280.20
CIPLA LTD 1316.65 22.37 3.23 106356.70 1165.55 1672.20
FERMENTA BIOTECH LIMITED 312.75 10.40 2.35 920.45 252.15 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.31 31.07 4.50 247.60 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 580.85 29.04 4.90 1679.27 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8381.00 100.72 26.22 20952.50 7630.00 10653.05
BLISS GVS PHARMA LTD 267.75 36.48 2.56 2832.50 105.05 280.20

SUNREST LIFESCIENCE LTD shareholding pattern

Holding
46.49%
53.5%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

SUNREST LIFESCIENCE LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
36.10 -0.55 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 36.30
  • 26 Days 37.40
  • 10 Days 36.70
  • 50 Days 37.70
  • 12 Days 36.90
  • 100 Days 39.50
  • 20 Days 37.30
  • 200 Days 44.00
36.67 PIVOT
First Support 35.93 First Resistance 37.03 Second Support 35.57 Second Resistance 37.77 Third Support 34.83 Third Resistance 38.13
RSI 45.81 ADX 8.65 MACD -0.57 Williams % R -68.00 Commodity Channel Index (CCI) -51.93
Date 2026-04-29 Week 2240.00 Same Day 3200.00 Month 4000.00
1 Year 0.94 3 Year 0.79
Over 1 Month
-1.89% down
Over 1 Year
-26.03% down
Over 3 Months
23.25% down
Over 3 Years
-20.11% down
Over 6 Months
-16.99% down
Over 5 Years
0.00% down

SUNREST LIFESCIENCE LTD Corporate Actions

Top Gainers

Top Losers

SUNREST LIFESCIENCE LTD Share Price

Sunrest Lifescience Limited was originally incorporated as 'Sunrest Lifescience Private Limited' as a Private Company vide Certificate of Incorporation dated October 30, 2017, with the Registrar of Companies, Gujarat. Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to 'Sunrest Lifescience Limited' on March 21, 2023.

The Company is engaged in marketing of OTC generic pharmaceutical products into domestic market. The Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.

The Company gets product manufactured from one of their Group Company, Trilend Pharmaceuticals Private Limited. Apart from this, Company acquired 11,000 equity shares of Trilend, constituting 9.90% of its paid-up share capital.

The Company came up with its Initial Public Offering of 12,91,200 Equity Shares of Rs 10/- each by raising funds aggregating to Rs 10.84 Crore through Fresh Offer in November, 2023.

The Company has acquired 51.45% stake in the Hetvi Lifesciences Private Limited, making it a subsidiary of the Company on March 29, 2025.

Parent organization Indian Private
NSE symbol SUNREST
Founded 2017
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sunrest Lifescience Ltd?

Answer Field

Sunrest Lifescience Ltd share price is for NSE ₹ 36.10 & for BSE ₹ 0.00 as on Apr 30 2026 03:13 PM.

What is the Market Cap of Sunrest Lifescience Ltd Share?

Answer Field

The market cap of Sunrest Lifescience Ltd for NSE ₹ 31.00 & for BSE ₹ 0.00 as on Apr 30 2026 03:13 PM.

What is the 52 Week High and Low of Sunrest Lifescience Ltd?

Answer Field

The 52 Week High and Low of Sunrest Lifescience Ltd for NSE is ₹ 54.44 and ₹ 26.37 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Sunrest Lifescience Ltd?

Answer Field

The 1 year returns on the stock has been -26.03%.

What is the P/E Ratio of Sunrest Lifescience Ltd Share?

Answer Field

As on Apr 30 2026 03:13 PM the price-to-earnings (PE) ratio for Sunrest Lifescience Ltd share is 15.58.

What is the PB ratio of Sunrest Lifescience Ltd Share?

Answer Field

As on Apr 30 2026 03:13 PM, the price-to-book (PB) ratio for Sunrest Lifescience Ltd share is 36.35.

How to Buy Sunrest Lifescience Ltd Share?

Answer Field

You can trade in Sunrest Lifescience Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sunrest Lifescience Ltd Share on Bajaj Broking App?

Answer Field

To buy Sunrest Lifescience Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sunrest Lifescience Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|